ViCentra Netherlands United States of America United Kingdom

Led by new investor Innovation Industries, with matching contributions from existing investors, Partners in Equity and Invest-NL, the $85M round also drew support from EQT Life Sciences and Health Innovations, demonstrating strong confidence in ViCentra's next phase of growthFresh capital fuels scale-up, regulatory pathway, and commercialization of Kaleido 2, the world's smallest, lightest, and only lifestyle-oriented insulin patch pump in its classView original content:https://www.prnewswire.co.uk/news-releases/vicentra-raises-85m-to-scale-manufacturing-and-accelerate-market-penetration-of-kaleido-insulin-patch-pump-302543879.html